2014 Q1/Global Life Sciences


Summary

Full results


Changes in rank are compared to 2013 Q4/Global Life Sciences. Since then, 2 sites entered the survey, 2 sites left the survey and 55 sites could not be included in the rankings (7 more since last time).

Details

Scores

Percentage Failures




Rank Name Exact overall
same Idenix Pharmaceuticals 8.38
new Cytogen 8.20
- 1 Kyowa Hakko Kirin UK 7.94
+ 3 Galenica AG 7.41
- 2 Kyorin Holdings 7.40
- 1 Biotecnol 7.13
+ 52 Questcor 7.11
+ 1 Taisho Pharmaceutical 6.98
+ 1 EISAI UK 6.95
- 4 Wockhardt 6.76
- 3 Kaken Pharmaceutical 6.74
- 1 Yakult UK 6.47
+ 2 Actelion UK 6.40
- 1 Servier UK 6.28
+ 2 Vectura 6.02
+ 11 EISAI 6.02
+ 167 Advaxis 5.95
+ 6 Otsuka Pharmaceuticals Europe 5.91
+ 17 Wockhardt UK 5.87
+ 54 Genzyme UK 5.78
+ 2 Meda Pharmaceuticals 5.77
- 8 Genmab 5.72
+ 25 AEterna Zentaris 5.59
+ 45 Actelion 5.50
+ 5 Otsuka Pharmaceuticals 5.42
+ 63 Zambon 5.41
+ 14 Valeant Pharmaceuticals 5.35
same Recordati 5.34
+ 3 Dainippon Sumitomo 5.24
+ 1 Dusa Pharmaceuticals 5.23
+ 3 QLT 5.23
+ 5 Stallergenes 5.14
+ 125 Novartis UK 5.12
+ 4 Santen 5.10
+ 58 BTG International 5.04
+ 40 Vitrolife 5.03
+ 94 Actavis 5.02
+ 4 Sanofi UK 4.99
+ 4 Astrazeneca Uk 4.99
+ 4 Laboratoires Thea 4.94
+ 4 Covence 4.92
+ 132 Chugai - Pharma 4.88
+ 14 Boehringer Ingelheim 4.86
+ 19 Bavarian Nordic 4.84
+ 21 Agennix 4.84
+ 37 Apotex 4.84
+ 13 CSL Behring UK 4.81
+ 3 Stallergenes UK 4.79
+ 57 Auxilium Pharmaceuticals 4.79
+ 54 Galderma 4.78
- 26 MorphoSys 4.78
+ 42 Mylan 4.76
- 24 Bayer Schering Pharma 4.76
- 15 Pfizer UK 4.71
- 34 KRKA 4.68
- 36 Aptalis Pharma 4.65
- 45 Debiopharm 4.63
- 2 Alcon 4.60
+ 11 Alkermes 4.58
- 20 Daiichi-Sankyo UK 4.53
+ 24 Vianex 4.53
- 10 Hikma Pharmaceuticals 4.52
+ 16 Teijin 4.52
- 31 Nektar Therapeutics 4.51
- 10 Kissei 4.50
+ 45 Nippon Chemiphar 4.50
+ 146 Mochida 4.50
+ 35 Anavex Life Sciences Corp 4.50
- 16 Genus 4.49
- 44 Galapagos 4.48
- 6 Shire 4.48
- 5 Lundbeck 4.46
- 5 Avanir Pharmaceuticals 4.46
+ 16 Towa Pharmaceutical 4.45
- 40 Astellas Europe 4.45
+ 4 Onyx Pharmaceuticals 4.42
+ 10 Boehringer Ingelheim UK 4.41
- 7 Sunpharma Europe 4.39
+ 7 Biogen Idec 4.34
- 5 Nippon Kayaku 4.34
+ 29 CinnaGen 4.33
+ 25 Ipsen 4.31
- 34 Roche 4.30
+ 60 Mitsubishi Tanabe 4.24
- 4 Servier 4.23
+ 11 Senju Pharmaceutical 4.22
+ 80 Akorn 4.22
+ 20 Orion Pharma 4.21
+ 9 Gruenenthal 4.20
- 6 Chiesi 4.20
+ 9 Glenmark Pharmaceuticals Europe 4.20
- 42 MediGene 4.20
- 31 Bosnalijek 4.15
- 6 Square Pharmaceuticals 4.15
+ 90 Merck & Co UK 4.13
- 24 Astrazeneca 4.12
- 2 Cubist Pharmaceuticals 4.05
+ 40 Pharmstandard 4.05
+ 40 Stada 4.02
- 23 Hospira UK 4.01
- 9 Exelixis 3.99
same Vertex Pharmaceuticals 3.98
- 49 InterMune 3.96
+ 1 Ferozsons Laboratories 3.96
+ 25 Seattle Genetics 3.96
- 24 Menarini UK 3.96
- 61 Fresenius Medical Care 3.89
+ 20 Torrent Pharmacueticals 3.89
+ 3 Astellas 3.88
+ 52 Melior Discovery 3.86
+ 138 Endo Pharmaceuticals 3.86
+ 14 Cangene 3.85
+ 3 Novartis 3.84
- 53 Asahi Kasei 3.80
+ 35 Arena Pharmaceuticals 3.79
- 69 Alkaloid 3.79
+ 7 Zentiva 3.79
+ 30 Meiji Holdings 3.78
same Menarini 3.78
- 24 Intas Biopharmaceuticals 3.78
+ 51 Regeneron 3.76
- 5 Pharma Nord 3.71
- 2 Hutchison China MediTech 3.70
- 2 Targacept 3.70
- 2 Elder Pharmaceuticals 3.69
+ 39 Gilead Sciences 3.67
+ 18 Johnson & Johnson 3.66
- 109 Lilly UK 3.63
+ 30 Seikagaku 3.62
- 16 Abbott 3.60
+ 18 Takeda 3.60
- 23 Teva Pharmaceutical Industries Ltd 3.58
- 1 ViroPharma 3.58
- 1 Allergan 3.58
- 1 MannKind Corporation 3.58
- 1 Kyowa Hakko Kirin 3.55
+ 16 Myriad Genetics 3.50
+ 3 China Pharmaceutical Group 3.49
- 2 Anika Therapeutics 3.44
+ 7 Merck KGaA 3.42
+ 27 ARIAD Pharmaceuticals 3.40
- 29 Therabel 3.40
- 23 Eskayef Bangladesh Ltd 3.38
+ 7 Piramel Enterprises 3.35
- 9 Daiichi-Sankyo 3.34
- 21 Salix 3.32
+ 7 Alfa Wassermann 3.30
- 57 Merz 3.29
+ 6 Nissan Chemical 3.29
- 23 Allergan UK 3.29
+ 5 Forest 3.28
+ 44 Julphar 3.27
+ 7 Ferring 3.25
- 8 BioMarin Pharmaceutical 3.25
- 12 The Medicines Co 3.21
+ 1 Acorda Therapeutics 3.20
- 5 Isis Pharmaceuticals 3.18
+ 12 Emergent BioSolutions 3.17
+ 23 Handok 3.17
+ 1 PDL BioPharma 3.15
+ 3 Laboratoires Thea UK 3.14
+ 7 ALK-Abello 3.13
+ 3 CSL Behring 3.12
+ 23 Maruho 3.08
+ 6 GlaxoSmithKline 3.05
+ 67 Lupin Pharmaceuticals 3.05
+ 23 Leo Pharma 3.05
+ 7 Italfaraco 2.99
- 40 Pharmacosmos 2.98
+ 7 SOBI 2.97
+ 8 Perrigo 2.96
+ 71 Elan 2.96
+ 46 Laboratorios Farmaceuticos ROVI 2.96
+ 7 Perrigo UK 2.94
+ 1 Yakult Honsha 2.90
- 77 Alexion Pharmaceuticals 2.88
- 113 Nova Nordisk UK 2.87
+ 27 Leo Pharma UK 2.87
+ 39 Cerus 2.79
+ 27 Esteve 2.78
+ 10 Sigma-Tau 2.76
+ 10 Sanofi 2.76
+ 10 Medivation 2.75
+ 11 Johnson & Johnson UK 2.72
- 5 Purdue Pharma 2.70
+ 18 Lilly 2.69
+ 13 Panacea Biotec 2.68
+ 33 Sawai Pharmaceutical 2.64
- 71 Bayer UK & Ireland 2.63
+ 13 Kaneka 2.63
+ 7 Toray Industries 2.62
- 6 Diffusion Pharmaceuticals 2.57
- 51 Misubishi Pharma Europe 2.55
+ 50 Ego Pharmaceuticals 2.54
+ 16 Biocon 2.50
- 23 Paladin Labs 2.49
+ 39 Medivir Group 2.43
+ 31 Intermune UK 2.42
+ 2 Roche UK 2.41
- 6 Simcere Pharmaceutical 2.39
+ 11 SciClone Pharmaceuticals 2.39
same Baxter Healthcare UK 2.38
+ 12 Incepta Pharmaceuticals 2.38
+ 12 Nippon Shinyaku 2.36
+ 12 Hisamitsu 2.34
- 7 Jazz Pharmaceuticals 2.33
+ 13 Cipla 2.32
+ 34 Strides Arcolab 2.29
+ 23 Orchid Pharmaceuticals 2.28
+ 14 Covidien 2.27
+ 16 Alphapharm 2.27
+ 10 Merz UK 2.27
- 50 Array BioPharma 2.26
+ 27 Taro Pharmaceutical Industries 2.26
+ 8 Merck & Co 2.25
- 8 Lavipharm 2.25
- 7 Baxter International 2.24
- 35 Getz Pharma 2.21
+ 7 Bionovo 2.19
+ 8 Unilab 2.17
- 81 Almirall Spain 2.15
+ 9 Aspen Pharmacare 2.14
+ 15 Par Pharmaceutical Companies 2.13
+ 6 Maxygen 2.09
+ 9 Santen Europe 2.09
- 38 Genzyme 2.08
+ 8 Pfizer 2.07
- 22 Abbott Uk 2.05
- 114 Celgene 2.01
+ 10 Amgen UK 1.95
- 6 Veloxis Pharmaceuticals 1.94
+ 7 Bial Portela 1.91
+ 4 Bristol-Myers Squibb 1.88
- 45 Faes Farma 1.82
+ 11 Bristol-Myers Squibb UK 1.80
+ 11 Sun Pharmaceuticals 1.65
- 40 Bioniche Life Sciences 1.65
+ 7 Patheon 1.55
+ 9 Gedeon Richter 1.37
+ 11 NPS Pharmaceuticals 1.37
+ 9 Hospira 1.11
+ 10 Beximco Pharmaceuticals 1.04
+ 10 Sinovac Biotech 0.96
new Merck Sharp & Dohme, MSD 0.59
+ 9 Sinopharm 0.07